Tags

Type your tag names separated by a space and hit enter

Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
Bull World Health Organ. 2020 Sep 01; 98(9):588-589.BW

Abstract

Melanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims.

Pub Type(s)

News

Language

eng

PubMed ID

33012858

Citation

"Melanie Saville: the End-to-end Process Needed for a SARS-CoV-2 Vaccine." Bulletin of the World Health Organization, vol. 98, no. 9, 2020, pp. 588-589.
Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine. Bull World Health Organ. 2020;98(9):588-589.
(2020). Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine. Bulletin of the World Health Organization, 98(9), 588-589. https://doi.org/10.2471/BLT.20.030920
Melanie Saville: the End-to-end Process Needed for a SARS-CoV-2 Vaccine. Bull World Health Organ. 2020 Sep 1;98(9):588-589. PubMed PMID: 33012858.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine. PY - 2020/10/5/entrez PY - 2020/10/6/pubmed PY - 2020/10/21/medline SP - 588 EP - 589 JF - Bulletin of the World Health Organization JO - Bull World Health Organ VL - 98 IS - 9 N2 - Melanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims. SN - 1564-0604 UR - https://www.unboundmedicine.com/medline/citation/33012858/Melanie_Saville:_the_end_to_end_process_needed_for_a_SARS_CoV_2_vaccine_ DB - PRIME DP - Unbound Medicine ER -